MedTech Spectrum

Article Name Medtech

Boston Scientific Announces Agreement to Acquire Axonics, Inc.

Acquisition to expand urology portfolio with differentiated technologies to treat urinary and bowel dysfunction

09th January, 2024

Fresenius Medical Care Executes on Its Strategic Portfolio Optimization Program and Announces Key Transactions

Strategic Divestments and Portfolio Streamlining

09th January, 2024

FDA approves Medtronic Percept™ RC neurostimulator with exclusive BrainSense™ technology

Rechargeable neurostimulator joins the Medtronic Percept™ family – the first and only deep brain stimulation system with sensing, directionality, and advanced programming.

09th January, 2024

Baracoda Unveils BMind, the World's First Smart Mirror for Mental Wellness

Personalized mental health coaching based on mood identiﬁcation available on CareOS operating system

08th January, 2024

Endotronix Submits PMA Application for its Cordella Pulmonary Artery Sensor System

Cordella PA Sensor System's Pivotal Regulatory Step

08th January, 2024

Medtronic receives CE Mark for its next generation Micra leadless pacing systems

New pacemakers offer 40% more battery life, extend Medtronic legacy of pacing leadership

08th January, 2024

“The Open Innovation Program has become a trend in the molecular diagnostics industry”

Established in 2000, South Korea based Seegene Inc is a leader in molecular diagnostics and achieved remarkable financial success with over $1 billion in revenue and 65 per cent gross margins. With a mission for a disease-free world and proactive pandemic prevention, Seegene seamlessly integrates high multiplex diagnostic assays with automated testing systems. In an interaction with BioSpectrum & MedTech Spectrum, Dr Seong-Youl Kim, Seegene's Senior Vice President, shares insights on the company, the molecular diagnostics landscape, challenges and opportunities etc.

08th January, 2024

Global Neuroscience Conference SIGN begins in Hyderabad Today

SIGN discusses medical innovations including Ultrasound Breakthrough in Tumor Treatment, AI and mini robots for brain surgeries

05th January, 2024

Thermo Fisher Scientific Launches PangenomiX Array to Support Population-Scale Disease Studies and Pharmacogenomics Research

Most comprehensive and ethnically diverse genomic coverage on a high throughput microarray delivers multi-disease and pharmacogenomic research analysis across global populations

05th January, 2024

Harrow Partners with Leading Healthcare Market Access Technology Platforms

Agreements Support the Upcoming Launch of VEVYE®

04th January, 2024

Sonendo Partners With BEST for Dentistry to Continue Expanding Access to the Innovative GentleWave® Procedure

As a Result of the Agreement, Additional Dental Practices Can Offer This Elevated, Modern Root Canal Treatment That Promotes Pain-free, Fast Healing

04th January, 2024

K Health Announces Collaboration with Mayo Clinic for Development of Cardiac Clinical AI Solution

K Health will work with Mayo Clinic to develop and test its bespoke preventative cardiology care technology

04th January, 2024

New England Orthopedic Surgeons Selects athenahealth to Transform Patient Experience, Optimize Performance, and Support Continued Growth

Leading orthopedic provider adopting athenaOne® for its value as a modern and comprehensive suite of EHR, practice management, and patient engagement solutions

04th January, 2024